LEE S NEWMAN, MD
Osteopathic Medicine at Jackson St, Denver, CO
License number
Colorado 25804
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Colorado 25804
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
1400 Jackson St, Denver, CO 80206
Phone
(303) 388-4461
(303) 270-2174 (Fax)
(303) 270-2174 (Fax)
Personal information
See more information about LEE S NEWMAN at radaris.comName
Address
Phone
5900 E 6Th Avenue Pkwy, Denver, CO 80220
16045 E 97Th Ave, Commerce City, CO 80022
495 Dayton St, Denver, CO 80231
5900 6Th Ave, Denver, CO 80220
900 6Th Ave, Denver, CO 80218
Professional information
See more information about LEE S NEWMAN at trustoria.com
Director At Mountain And Plains Education And Research Center
Director At Mountain And Plains Education And Research Center
Position:
Chief Medical Information Officer at Axion Health, Inc., Professor at University of Colorado at Denver and Health Sciences Center, Director at Mountain and Plains Education and Research Center
Location:
Greater Denver Area
Industry:
Information Technology and Services
Work:
Axion Health, Inc.
since Aug 2012
-
Chief Medical Information Officer
University of Colorado at Denver and Health Sciences Center
since Jul 1987
-
Professor
Mountain and Plains Education and Research Center
- Colorado School of Public Health, Aurora, CO since 2007
-
Director
Axion Health Inc.
Jul 2004 - Aug 2012
-
CEO
National Jewish Medical and Research Center
Jul 1987 - Dec 2004
-
Professor and Staff Physician
Education:
University of Colorado School of Medicine 1984 - 1987
Fellowship, Pulmonary and Critical Care Medicine Emory University School of Medicine 1980 - 1983
Internship and Residency, Internal Medicine Vanderbilt University School of Medicine 1976 - 1980
MD, Medicine Cornell University 1975 - 1977
MA, Social Psychology Amherst College 1971 - 1975
BA, Psychology
Fellowship, Pulmonary and Critical Care Medicine Emory University School of Medicine 1980 - 1983
Internship and Residency, Internal Medicine Vanderbilt University School of Medicine 1976 - 1980
MD, Medicine Cornell University 1975 - 1977
MA, Social Psychology Amherst College 1971 - 1975
BA, Psychology
Honor & Awards:
Fellow, American College of Occupational and Environmental Medicine, 2004-
Fellow, American College of Chest Physicians, 1990-
Fellow, Collegium Ramazzini, 2004-
Castle Connolly Top Doctor Award, 2001-2010
Best Doctors in America, 2002-2010
Lee S Newman, Aurora CO
Lee S Newman, Aurora CO
Specialties:
Pulmonologist
Address:
13001 E. 17Th Place, Aurora, CO 80045
Education:
Vanderbilt University, School of Medicine - Doctor of Medicine
University of Colorado Hospital-Anschutz Inpatient Pavilion - Fellowship - Pulmonary Disease (Internal Medicine)
University of Colorado Hospital-Anschutz Inpatient Pavilion - Fellowship - Pulmonary Disease (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Methods And Compositions For 10Beryllium Complex Probes
Methods And Compositions For 10Beryllium Complex Probes
US Patent:
2007001, Jan 18, 2007
Filed:
Jul 14, 2006
Appl. No.:
11/486682
Inventors:
Richard Sawyer - Rockville MD, US
Brian Day - Englewood CO, US
Lee Newman - Denver CO, US
Brian Day - Englewood CO, US
Lee Newman - Denver CO, US
International Classification:
A61K 51/00
US Classification:
424001110
Abstract:
The present invention concerns methods and compositions for making and using Be complexes of defined compositions, which may have multiple functionalities and/or binding specificities. In various embodiment, Beryllium (Be) complexes may include Be such as Be and Be complexes. Such complexes find use in a wide variety of applications, particularly in the field of treatment, detection and/or diagnosis of infections, diseases and other health-related conditions, including but not limited to cancer, autoimmune disease, cardiovascular disease, metabolic diseases, degenerative diseases, and organ transplant rejection. In addition, a Be complex may be used in a BeLPT assay
Methods And Compositions For Beryllium-Induced Disease
Methods And Compositions For Beryllium-Induced Disease
US Patent:
2006026, Nov 23, 2006
Filed:
Mar 10, 2006
Appl. No.:
11/373581
Inventors:
Andrew Fontenot - Denver CO, US
Brian Kotzin - Westlake CA, US
Lee Newman - Denver CO, US
Lisa Maier - Denver CO, US
Brian Kotzin - Westlake CA, US
Lee Newman - Denver CO, US
Lisa Maier - Denver CO, US
International Classification:
C12Q 1/00, G01N 33/567, G01N 33/20
US Classification:
435004000, 435007200, 436080000
Abstract:
The present invention provides for methods for detection, diagnosis and prognosis of beryllium-induced disease. In one embodiment, the methods include exposing immune cells from subjects suspected of having beryllium-induced disease to beryllium and assessing the Th-1 cytokines produced. Other embodiments include the use of exposing immune cells from subjects suspected of having beryllium-induced disease to beryllium and assessing Th-1 cytokines produced and using these assessments to indicate the stage of progression of the disease. Therapeutic methods involve assessing the onset or progression of beryllium-induced disease before during and after exposure to a treatment for the disease.
Methods For Treatment Of Thiol-Containing Compound Deficient Conditions
Methods For Treatment Of Thiol-Containing Compound Deficient Conditions
US Patent:
7498047, Mar 3, 2009
Filed:
Aug 24, 2005
Appl. No.:
11/211369
Inventors:
Brian J. Day - Englewood CO, US
Richard T. Sawyer - Rockville MD, US
Lee S. Newman - Denver CO, US
Richard T. Sawyer - Rockville MD, US
Lee S. Newman - Denver CO, US
Assignee:
National Jewish Medical and Research Center - Denver CO
International Classification:
A61K 35/42
US Classification:
424557, 435 77
Abstract:
Methods for therapy of cystic fibrosis and other conditions are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system (i. e. ABC transporters such as MDR-1 or MRP-2) in cells. Other embodiments include the use of agents to modulate transport of thiol-containing compounds within the cell. Therapeutic methods involve the administration of such agents to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of thiol-containing compound transport.